Organism ID | Organism Name | Taxonomy Level | Family | SuperKingdom | Isolation Part | Collection Location | Collection Time | Reference |
---|---|---|---|---|---|---|---|---|
NPO1797 | Homo sapiens | Species | Hominidae | Eukaryota | urine |
PMID[19309105] |
||
NPO1797 | Homo sapiens | Species | Hominidae | Eukaryota | blood |
PMID[7866557] |
||
NPO21963 | Hypericum japonicum | Species | Hypericaceae | Eukaryota | TCMID* | |||
NPO10021 | Nerium oleander | Species | Apocynaceae | Eukaryota | TCMID* |
Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT219 | Individual Protein | Alpha-1a adrenergic receptor | Rattus norvegicus | Ki | = | 977.24 | nM | 8831777 |
NPT3051 | Individual Protein | Alpha-1a adrenergic receptor | Bos taurus | Ki | = | 933.25 | nM | 8831777 |
NPT4554 | Individual Protein | Alpha-1b adrenergic receptor | Mesocricetus auratus | Ki | = | 1258.93 | nM | 8831777 |
NPT3048 | Individual Protein | Alpha-1d adrenergic receptor | Rattus norvegicus | Ki | = | 162.18 | nM | 8831777 |
NPT219 | Individual Protein | Alpha-1a adrenergic receptor | Rattus norvegicus | EC50 | = | 1659.59 | nM | 8831777 |
NPT1788 | Individual Protein | Alpha-1a adrenergic receptor | Homo sapiens | EC50 | = | 2951.21 | nM | 8831777 |
NPT220 | Individual Protein | Alpha-1b adrenergic receptor | Rattus norvegicus | EC50 | = | 10964.78 | nM | 8831777 |
NPT3048 | Individual Protein | Alpha-1d adrenergic receptor | Rattus norvegicus | EC50 | = | 154.88 | nM | 8831777 |
NPT968 | Protein Family | Adrenergic receptor alpha-1 | Rattus norvegicus | IC50 | = | 2000 | nM | 6142954 |
NPT969 | Protein Family | Adrenergic receptor alpha-2 | Rattus norvegicus | IC50 | = | 520 | nM | 6142954 |
NPT2 | Others | Unspecified | Ki | = | 2500 | nM | 3020250 | |
NPT2 | Others | Unspecified | Ki | = | 6100 | nM | 3020250 | |
NPT971 | Protein Family | Adrenergic receptor alpha-2 | Homo sapiens | Ki | = | 390 | nM | 3020250 |
NPT4557 | Others | Adrenergic receptor beta; ADRB1 & ADRB3 | Homo sapiens | Ki | = | 13000 | nM | 3020250 |
NPT938 | Organism | Cavia porcellus | Cavia porcellus | EC50 | = | 27000 | nM | 3020250 |
NPT938 | Organism | Cavia porcellus | Cavia porcellus | EC50 | = | 26000 | nM | 3020250 |
NPT969 | Protein Family | Adrenergic receptor alpha-2 | Rattus norvegicus | Ki | = | 270 | nM | 6296387 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | ED40 | = | 0.9 | ug kg-1 | 2896247 |
NPT968 | Protein Family | Adrenergic receptor alpha-1 | Rattus norvegicus | Ki | = | 6100 | nM | 8254623 |
NPT969 | Protein Family | Adrenergic receptor alpha-2 | Rattus norvegicus | Ki | = | 390 | nM | 8254623 |
NPT4558 | Individual Protein | Beta-1 adrenergic receptor | Rattus norvegicus | Ki | = | 13000 | nM | 8254623 |
NPT938 | Organism | Cavia porcellus | Cavia porcellus | EC50 | = | 6000 | nM | 8254623 |
NPT1386 | Protein Family | Adrenergic receptor beta | Homo sapiens | EC50 | = | 6000 | nM | 6124637 |
NPT969 | Protein Family | Adrenergic receptor alpha-2 | Rattus norvegicus | IC50 | = | 78 | nM | 2567783 |
NPT26 | Individual Protein | Reverse transcriptase | Human immunodeficiency virus 1 | IC50 | > | 200 | ug/ml | 1710653 |
NPT163 | Individual Protein | Nuclear factor NF-kappa-B p105 subunit | Homo sapiens | Potency | = | 3548.1 | nM | PubChem BioAssay data set |
NPT537 | Individual Protein | Ras-related protein Rab-9A | Homo sapiens | Potency | = | 91999.7 | nM | PubChem BioAssay data set |
NPT210 | Individual Protein | Thyroid stimulating hormone receptor | Homo sapiens | Potency | = | 19952.6 | nM | PubChem BioAssay data set |
NPT211 | Individual Protein | Hypoxia-inducible factor 1 alpha | Homo sapiens | Potency | = | 251.2 | nM | PubChem BioAssay data set |
NPT242 | Individual Protein | Dopamine D1 receptor | Homo sapiens | Potency | 5623.4 | nM | PubChem BioAssay data set | |
NPT7 | Individual Protein | Thioredoxin reductase 1, cytoplasmic | Rattus norvegicus | Potency | 1122 | nM | PubChem BioAssay data set | |
NPT71 | Cell Line | HEK293 | Homo sapiens | Potency | 4107.8 | nM | PubChem BioAssay data set | |
NPT242 | Individual Protein | Dopamine D1 receptor | Homo sapiens | Potency | 1835.6 | nM | PubChem BioAssay data set | |
NPT1788 | Individual Protein | Alpha-1a adrenergic receptor | Homo sapiens | EC50 | = | 55 | nM | 25813897 |
NPT1789 | Individual Protein | Alpha-1b adrenergic receptor | Homo sapiens | EC50 | = | 5.9 | nM | 25813897 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC137096 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
0.916 | High Similarity | NPC236347 |
0.916 | High Similarity | NPC323775 |
0.9115 | High Similarity | NPC10286 |
0.9115 | High Similarity | NPC213 |
0.9 | High Similarity | NPC322366 |
0.8718 | High Similarity | NPC85276 |
0.8716 | High Similarity | NPC68055 |
0.8624 | High Similarity | NPC327226 |
0.8584 | High Similarity | NPC145638 |
0.8584 | High Similarity | NPC290566 |
0.8571 | High Similarity | NPC169207 |
0.8571 | High Similarity | NPC118522 |
0.8571 | High Similarity | NPC115627 |
0.8468 | Intermediate Similarity | NPC226778 |
0.8468 | Intermediate Similarity | NPC150254 |
0.8468 | Intermediate Similarity | NPC304761 |
0.8468 | Intermediate Similarity | NPC147000 |
0.8205 | Intermediate Similarity | NPC146422 |
0.8203 | Intermediate Similarity | NPC208757 |
0.8108 | Intermediate Similarity | NPC125732 |
0.8073 | Intermediate Similarity | NPC20142 |
0.8073 | Intermediate Similarity | NPC215351 |
0.8036 | Intermediate Similarity | NPC155847 |
0.8036 | Intermediate Similarity | NPC289381 |
0.8018 | Intermediate Similarity | NPC474073 |
0.8018 | Intermediate Similarity | NPC164514 |
0.8018 | Intermediate Similarity | NPC108606 |
0.8018 | Intermediate Similarity | NPC226096 |
0.8018 | Intermediate Similarity | NPC303611 |
0.8018 | Intermediate Similarity | NPC290515 |
0.7984 | Intermediate Similarity | NPC326599 |
0.7984 | Intermediate Similarity | NPC329595 |
0.7876 | Intermediate Similarity | NPC214200 |
0.7876 | Intermediate Similarity | NPC228400 |
0.7874 | Intermediate Similarity | NPC318965 |
0.7798 | Intermediate Similarity | NPC312304 |
0.7778 | Intermediate Similarity | NPC298486 |
0.7769 | Intermediate Similarity | NPC142599 |
0.7739 | Intermediate Similarity | NPC178902 |
0.7719 | Intermediate Similarity | NPC29601 |
0.7719 | Intermediate Similarity | NPC174911 |
0.7717 | Intermediate Similarity | NPC13020 |
0.7717 | Intermediate Similarity | NPC140359 |
0.7717 | Intermediate Similarity | NPC307020 |
0.7667 | Intermediate Similarity | NPC21890 |
0.7658 | Intermediate Similarity | NPC325292 |
0.7658 | Intermediate Similarity | NPC138117 |
0.7652 | Intermediate Similarity | NPC300020 |
0.7652 | Intermediate Similarity | NPC33338 |
0.7652 | Intermediate Similarity | NPC302171 |
0.7647 | Intermediate Similarity | NPC316052 |
0.7615 | Intermediate Similarity | NPC27974 |
0.76 | Intermediate Similarity | NPC283760 |
0.7586 | Intermediate Similarity | NPC235762 |
0.7586 | Intermediate Similarity | NPC471228 |
0.7565 | Intermediate Similarity | NPC130103 |
0.7565 | Intermediate Similarity | NPC294741 |
0.7542 | Intermediate Similarity | NPC231705 |
0.7522 | Intermediate Similarity | NPC313650 |
0.7521 | Intermediate Similarity | NPC475225 |
0.75 | Intermediate Similarity | NPC214988 |
0.75 | Intermediate Similarity | NPC258056 |
0.75 | Intermediate Similarity | NPC106551 |
0.75 | Intermediate Similarity | NPC188867 |
0.75 | Intermediate Similarity | NPC281686 |
0.75 | Intermediate Similarity | NPC172046 |
0.7479 | Intermediate Similarity | NPC142297 |
0.7477 | Intermediate Similarity | NPC300017 |
0.7466 | Intermediate Similarity | NPC37205 |
0.7466 | Intermediate Similarity | NPC160931 |
0.7462 | Intermediate Similarity | NPC141739 |
0.7462 | Intermediate Similarity | NPC320242 |
0.7462 | Intermediate Similarity | NPC136112 |
0.7458 | Intermediate Similarity | NPC471350 |
0.7442 | Intermediate Similarity | NPC318777 |
0.744 | Intermediate Similarity | NPC120075 |
0.7438 | Intermediate Similarity | NPC474149 |
0.7417 | Intermediate Similarity | NPC153690 |
0.7391 | Intermediate Similarity | NPC168861 |
0.7391 | Intermediate Similarity | NPC107619 |
0.7391 | Intermediate Similarity | NPC88420 |
0.7391 | Intermediate Similarity | NPC152097 |
0.7388 | Intermediate Similarity | NPC88667 |
0.7377 | Intermediate Similarity | NPC163674 |
0.7373 | Intermediate Similarity | NPC323810 |
0.7355 | Intermediate Similarity | NPC24777 |
0.7355 | Intermediate Similarity | NPC473524 |
0.735 | Intermediate Similarity | NPC110764 |
0.7348 | Intermediate Similarity | NPC161593 |
0.7348 | Intermediate Similarity | NPC145888 |
0.7348 | Intermediate Similarity | NPC16031 |
0.7345 | Intermediate Similarity | NPC3358 |
0.7345 | Intermediate Similarity | NPC29373 |
0.7345 | Intermediate Similarity | NPC55903 |
0.7345 | Intermediate Similarity | NPC210497 |
0.7345 | Intermediate Similarity | NPC147284 |
0.7345 | Intermediate Similarity | NPC306884 |
0.7345 | Intermediate Similarity | NPC162314 |
0.7345 | Intermediate Similarity | NPC94139 |
0.7339 | Intermediate Similarity | NPC118202 |
0.7339 | Intermediate Similarity | NPC150837 |
0.7338 | Intermediate Similarity | NPC204546 |
0.7333 | Intermediate Similarity | NPC267237 |
0.7333 | Intermediate Similarity | NPC305603 |
0.7333 | Intermediate Similarity | NPC61033 |
0.7333 | Intermediate Similarity | NPC66834 |
0.7333 | Intermediate Similarity | NPC474352 |
0.7333 | Intermediate Similarity | NPC186469 |
0.7328 | Intermediate Similarity | NPC260775 |
0.7323 | Intermediate Similarity | NPC239697 |
0.7321 | Intermediate Similarity | NPC192 |
0.7319 | Intermediate Similarity | NPC170170 |
0.7319 | Intermediate Similarity | NPC219233 |
0.7319 | Intermediate Similarity | NPC211468 |
0.7311 | Intermediate Similarity | NPC42383 |
0.7297 | Intermediate Similarity | NPC104216 |
0.7293 | Intermediate Similarity | NPC271808 |
0.7287 | Intermediate Similarity | NPC474862 |
0.7281 | Intermediate Similarity | NPC245187 |
0.728 | Intermediate Similarity | NPC317254 |
0.7273 | Intermediate Similarity | NPC24101 |
0.7273 | Intermediate Similarity | NPC97811 |
0.7273 | Intermediate Similarity | NPC96224 |
0.7266 | Intermediate Similarity | NPC323123 |
0.7265 | Intermediate Similarity | NPC12931 |
0.7265 | Intermediate Similarity | NPC129373 |
0.7265 | Intermediate Similarity | NPC48730 |
0.7265 | Intermediate Similarity | NPC248396 |
0.7265 | Intermediate Similarity | NPC130756 |
0.7265 | Intermediate Similarity | NPC70677 |
0.7259 | Intermediate Similarity | NPC247018 |
0.7259 | Intermediate Similarity | NPC307123 |
0.7259 | Intermediate Similarity | NPC97870 |
0.7259 | Intermediate Similarity | NPC149379 |
0.7258 | Intermediate Similarity | NPC59387 |
0.7257 | Intermediate Similarity | NPC231150 |
0.7246 | Intermediate Similarity | NPC318591 |
0.7246 | Intermediate Similarity | NPC231163 |
0.7241 | Intermediate Similarity | NPC475078 |
0.7239 | Intermediate Similarity | NPC262641 |
0.7227 | Intermediate Similarity | NPC12278 |
0.7227 | Intermediate Similarity | NPC130817 |
0.7226 | Intermediate Similarity | NPC64205 |
0.7217 | Intermediate Similarity | NPC274678 |
0.7209 | Intermediate Similarity | NPC284078 |
0.7207 | Intermediate Similarity | NPC407 |
0.7207 | Intermediate Similarity | NPC307235 |
0.7207 | Intermediate Similarity | NPC23167 |
0.7188 | Intermediate Similarity | NPC268572 |
0.7183 | Intermediate Similarity | NPC294249 |
0.7179 | Intermediate Similarity | NPC216468 |
0.7179 | Intermediate Similarity | NPC132078 |
0.7179 | Intermediate Similarity | NPC131587 |
0.7179 | Intermediate Similarity | NPC51333 |
0.7179 | Intermediate Similarity | NPC128723 |
0.7179 | Intermediate Similarity | NPC78119 |
0.7176 | Intermediate Similarity | NPC217277 |
0.7174 | Intermediate Similarity | NPC470249 |
0.7168 | Intermediate Similarity | NPC47950 |
0.7168 | Intermediate Similarity | NPC300478 |
0.7165 | Intermediate Similarity | NPC283468 |
0.7164 | Intermediate Similarity | NPC471321 |
0.7164 | Intermediate Similarity | NPC471306 |
0.7155 | Intermediate Similarity | NPC312132 |
0.7155 | Intermediate Similarity | NPC259512 |
0.7154 | Intermediate Similarity | NPC211992 |
0.7154 | Intermediate Similarity | NPC27581 |
0.7143 | Intermediate Similarity | NPC108497 |
0.7143 | Intermediate Similarity | NPC25493 |
0.7143 | Intermediate Similarity | NPC113460 |
0.7143 | Intermediate Similarity | NPC321561 |
0.7143 | Intermediate Similarity | NPC19680 |
0.7132 | Intermediate Similarity | NPC17388 |
0.7132 | Intermediate Similarity | NPC53596 |
0.7132 | Intermediate Similarity | NPC289330 |
0.7132 | Intermediate Similarity | NPC321133 |
0.7132 | Intermediate Similarity | NPC471308 |
0.7132 | Intermediate Similarity | NPC160120 |
0.713 | Intermediate Similarity | NPC76938 |
0.7122 | Intermediate Similarity | NPC48202 |
0.7121 | Intermediate Similarity | NPC62101 |
0.7121 | Intermediate Similarity | NPC95733 |
0.712 | Intermediate Similarity | NPC26524 |
0.7119 | Intermediate Similarity | NPC72729 |
0.7119 | Intermediate Similarity | NPC166761 |
0.7119 | Intermediate Similarity | NPC213730 |
0.7117 | Intermediate Similarity | NPC155393 |
0.7117 | Intermediate Similarity | NPC197783 |
0.7109 | Intermediate Similarity | NPC317784 |
0.7109 | Intermediate Similarity | NPC122009 |
0.7109 | Intermediate Similarity | NPC142638 |
0.7105 | Intermediate Similarity | NPC304541 |
0.7094 | Intermediate Similarity | NPC79241 |
0.7094 | Intermediate Similarity | NPC109955 |
0.7094 | Intermediate Similarity | NPC6597 |
0.709 | Intermediate Similarity | NPC153990 |
0.709 | Intermediate Similarity | NPC477839 |
0.7087 | Intermediate Similarity | NPC82963 |
0.7083 | Intermediate Similarity | NPC475580 |
0.708 | Intermediate Similarity | NPC280347 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC137096 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
1.0 | High Similarity | NPD9615 | Approved |
1.0 | High Similarity | NPD9613 | Approved |
1.0 | High Similarity | NPD9616 | Approved |
0.9909 | High Similarity | NPD316 | Approved |
0.9196 | High Similarity | NPD9614 | Approved |
0.9196 | High Similarity | NPD9618 | Approved |
0.916 | High Similarity | NPD9619 | Approved |
0.916 | High Similarity | NPD9621 | Approved |
0.916 | High Similarity | NPD9620 | Approved |
0.9 | High Similarity | NPD858 | Approved |
0.9 | High Similarity | NPD599 | Approved |
0.9 | High Similarity | NPD859 | Approved |
0.9 | High Similarity | NPD602 | Approved |
0.8957 | High Similarity | NPD16 | Approved |
0.8957 | High Similarity | NPD856 | Approved |
0.8957 | High Similarity | NPD318 | Approved |
0.8957 | High Similarity | NPD317 | Approved |
0.8862 | High Similarity | NPD601 | Approved |
0.8862 | High Similarity | NPD598 | Approved |
0.8862 | High Similarity | NPD597 | Approved |
0.879 | High Similarity | NPD1136 | Approved |
0.879 | High Similarity | NPD1132 | Approved |
0.879 | High Similarity | NPD1130 | Approved |
0.8584 | High Similarity | NPD9380 | Clinical (unspecified phase) |
0.8583 | High Similarity | NPD2568 | Approved |
0.8571 | High Similarity | NPD9381 | Approved |
0.8571 | High Similarity | NPD3059 | Approved |
0.8571 | High Similarity | NPD3061 | Approved |
0.8571 | High Similarity | NPD9384 | Approved |
0.8571 | High Similarity | NPD3062 | Approved |
0.8512 | High Similarity | NPD2562 | Approved |
0.8512 | High Similarity | NPD2561 | Approved |
0.8468 | Intermediate Similarity | NPD10 | Approved |
0.8468 | Intermediate Similarity | NPD315 | Approved |
0.8468 | Intermediate Similarity | NPD311 | Approved |
0.8468 | Intermediate Similarity | NPD309 | Approved |
0.8468 | Intermediate Similarity | NPD310 | Approved |
0.8468 | Intermediate Similarity | NPD314 | Approved |
0.8443 | Intermediate Similarity | NPD9622 | Approved |
0.8438 | Intermediate Similarity | NPD823 | Approved |
0.8438 | Intermediate Similarity | NPD817 | Approved |
0.8438 | Intermediate Similarity | NPD5314 | Approved |
0.8306 | Intermediate Similarity | NPD1135 | Approved |
0.8306 | Intermediate Similarity | NPD1129 | Approved |
0.8306 | Intermediate Similarity | NPD1131 | Approved |
0.8306 | Intermediate Similarity | NPD1134 | Approved |
0.8306 | Intermediate Similarity | NPD1133 | Approved |
0.8226 | Intermediate Similarity | NPD9634 | Clinical (unspecified phase) |
0.8205 | Intermediate Similarity | NPD9379 | Approved |
0.8205 | Intermediate Similarity | NPD9377 | Approved |
0.816 | Intermediate Similarity | NPD3055 | Approved |
0.816 | Intermediate Similarity | NPD3053 | Approved |
0.8158 | Intermediate Similarity | NPD1444 | Approved |
0.8158 | Intermediate Similarity | NPD1445 | Approved |
0.8142 | Intermediate Similarity | NPD9610 | Approved |
0.8142 | Intermediate Similarity | NPD9608 | Approved |
0.808 | Intermediate Similarity | NPD5310 | Approved |
0.808 | Intermediate Similarity | NPD5311 | Approved |
0.8067 | Intermediate Similarity | NPD1793 | Approved |
0.8067 | Intermediate Similarity | NPD1791 | Approved |
0.806 | Intermediate Similarity | NPD3060 | Approved |
0.8018 | Intermediate Similarity | NPD9612 | Approved |
0.8018 | Intermediate Similarity | NPD9611 | Approved |
0.8018 | Intermediate Similarity | NPD9609 | Approved |
0.7969 | Intermediate Similarity | NPD600 | Approved |
0.7969 | Intermediate Similarity | NPD596 | Approved |
0.7949 | Intermediate Similarity | NPD1792 | Phase 2 |
0.7926 | Intermediate Similarity | NPD3638 | Discontinued |
0.7923 | Intermediate Similarity | NPD6405 | Approved |
0.7923 | Intermediate Similarity | NPD829 | Discontinued |
0.7923 | Intermediate Similarity | NPD6407 | Approved |
0.7846 | Intermediate Similarity | NPD3056 | Clinical (unspecified phase) |
0.784 | Intermediate Similarity | NPD5350 | Clinical (unspecified phase) |
0.784 | Intermediate Similarity | NPD5351 | Clinical (unspecified phase) |
0.7812 | Intermediate Similarity | NPD558 | Phase 2 |
0.7807 | Intermediate Similarity | NPD854 | Approved |
0.7807 | Intermediate Similarity | NPD855 | Approved |
0.7786 | Intermediate Similarity | NPD839 | Approved |
0.7786 | Intermediate Similarity | NPD840 | Approved |
0.7778 | Intermediate Similarity | NPD2231 | Phase 2 |
0.7778 | Intermediate Similarity | NPD2235 | Phase 2 |
0.7744 | Intermediate Similarity | NPD3054 | Approved |
0.7744 | Intermediate Similarity | NPD3052 | Approved |
0.7717 | Intermediate Similarity | NPD4659 | Approved |
0.771 | Intermediate Similarity | NPD2028 | Clinical (unspecified phase) |
0.7687 | Intermediate Similarity | NPD3552 | Approved |
0.7687 | Intermediate Similarity | NPD3555 | Approved |
0.7687 | Intermediate Similarity | NPD3553 | Approved |
0.7687 | Intermediate Similarity | NPD3554 | Approved |
0.7686 | Intermediate Similarity | NPD2228 | Approved |
0.7686 | Intermediate Similarity | NPD2229 | Approved |
0.7686 | Intermediate Similarity | NPD2234 | Approved |
0.7664 | Intermediate Similarity | NPD4162 | Approved |
0.7661 | Intermediate Similarity | NPD2227 | Clinical (unspecified phase) |
0.7643 | Intermediate Similarity | NPD3157 | Approved |
0.7643 | Intermediate Similarity | NPD3158 | Phase 1 |
0.763 | Intermediate Similarity | NPD1753 | Discontinued |
0.7619 | Intermediate Similarity | NPD2688 | Clinical (unspecified phase) |
0.7606 | Intermediate Similarity | NPD3687 | Approved |
0.7606 | Intermediate Similarity | NPD3686 | Approved |
0.76 | Intermediate Similarity | NPD1710 | Approved |
0.7597 | Intermediate Similarity | NPD4103 | Phase 2 |
0.7597 | Intermediate Similarity | NPD4104 | Clinical (unspecified phase) |
0.7581 | Intermediate Similarity | NPD828 | Approved |
0.754 | Intermediate Similarity | NPD5238 | Clinical (unspecified phase) |
0.752 | Intermediate Similarity | NPD2226 | Clinical (unspecified phase) |
0.7518 | Intermediate Similarity | NPD3645 | Discontinued |
0.75 | Intermediate Similarity | NPD9568 | Approved |
0.748 | Intermediate Similarity | NPD593 | Approved |
0.748 | Intermediate Similarity | NPD595 | Approved |
0.7466 | Intermediate Similarity | NPD2977 | Approved |
0.7466 | Intermediate Similarity | NPD2978 | Approved |
0.7463 | Intermediate Similarity | NPD2238 | Phase 2 |
0.7462 | Intermediate Similarity | NPD1794 | Approved |
0.7462 | Intermediate Similarity | NPD1817 | Approved |
0.7462 | Intermediate Similarity | NPD1818 | Approved |
0.7462 | Intermediate Similarity | NPD1819 | Approved |
0.7462 | Intermediate Similarity | NPD1820 | Approved |
0.746 | Intermediate Similarity | NPD4093 | Discontinued |
0.7445 | Intermediate Similarity | NPD9570 | Approved |
0.7407 | Intermediate Similarity | NPD555 | Phase 2 |
0.7388 | Intermediate Similarity | NPD2245 | Discovery |
0.7388 | Intermediate Similarity | NPD259 | Phase 1 |
0.7368 | Intermediate Similarity | NPD3136 | Phase 2 |
0.7364 | Intermediate Similarity | NPD2230 | Approved |
0.7364 | Intermediate Similarity | NPD2232 | Approved |
0.7364 | Intermediate Similarity | NPD2233 | Approved |
0.7355 | Intermediate Similarity | NPD551 | Approved |
0.7355 | Intermediate Similarity | NPD550 | Approved |
0.7348 | Intermediate Similarity | NPD9569 | Approved |
0.7319 | Intermediate Similarity | NPD1632 | Clinical (unspecified phase) |
0.728 | Intermediate Similarity | NPD256 | Approved |
0.728 | Intermediate Similarity | NPD255 | Approved |
0.7273 | Intermediate Similarity | NPD2194 | Approved |
0.7273 | Intermediate Similarity | NPD2195 | Approved |
0.7266 | Intermediate Similarity | NPD2554 | Approved |
0.7266 | Intermediate Similarity | NPD1751 | Approved |
0.7266 | Intermediate Similarity | NPD2029 | Clinical (unspecified phase) |
0.7266 | Intermediate Similarity | NPD2556 | Approved |
0.7265 | Intermediate Similarity | NPD289 | Clinical (unspecified phase) |
0.7259 | Intermediate Similarity | NPD1423 | Approved |
0.7259 | Intermediate Similarity | NPD554 | Clinical (unspecified phase) |
0.7246 | Intermediate Similarity | NPD2156 | Approved |
0.7246 | Intermediate Similarity | NPD2154 | Approved |
0.7246 | Intermediate Similarity | NPD2155 | Approved |
0.7244 | Intermediate Similarity | NPD5303 | Approved |
0.7244 | Intermediate Similarity | NPD5304 | Approved |
0.7239 | Intermediate Similarity | NPD3166 | Approved |
0.7239 | Intermediate Similarity | NPD3165 | Approved |
0.7239 | Intermediate Similarity | NPD3167 | Approved |
0.7239 | Intermediate Similarity | NPD3164 | Approved |
0.7231 | Intermediate Similarity | NPD4273 | Approved |
0.7217 | Intermediate Similarity | NPD844 | Approved |
0.7214 | Intermediate Similarity | NPD4257 | Approved |
0.7214 | Intermediate Similarity | NPD4256 | Phase 2 |
0.7188 | Intermediate Similarity | NPD770 | Discontinued |
0.7183 | Intermediate Similarity | NPD2677 | Approved |
0.7183 | Intermediate Similarity | NPD5241 | Discontinued |
0.7176 | Intermediate Similarity | NPD1755 | Approved |
0.7163 | Intermediate Similarity | NPD2976 | Clinical (unspecified phase) |
0.7155 | Intermediate Similarity | NPD288 | Approved |
0.7153 | Intermediate Similarity | NPD3536 | Discontinued |
0.7143 | Intermediate Similarity | NPD257 | Approved |
0.7143 | Intermediate Similarity | NPD6584 | Phase 3 |
0.7143 | Intermediate Similarity | NPD258 | Approved |
0.7143 | Intermediate Similarity | NPD7978 | Discontinued |
0.7143 | Intermediate Similarity | NPD7451 | Discontinued |
0.7132 | Intermediate Similarity | NPD2668 | Approved |
0.7132 | Intermediate Similarity | NPD3162 | Approved |
0.7132 | Intermediate Similarity | NPD2667 | Approved |
0.7132 | Intermediate Similarity | NPD3163 | Approved |
0.7111 | Intermediate Similarity | NPD9537 | Phase 1 |
0.7111 | Intermediate Similarity | NPD3180 | Approved |
0.7111 | Intermediate Similarity | NPD9536 | Phase 1 |
0.7111 | Intermediate Similarity | NPD3179 | Approved |
0.708 | Intermediate Similarity | NPD826 | Approved |
0.708 | Intermediate Similarity | NPD825 | Approved |
0.708 | Intermediate Similarity | NPD3597 | Clinical (unspecified phase) |
0.7071 | Intermediate Similarity | NPD3175 | Clinical (unspecified phase) |
0.7063 | Intermediate Similarity | NPD8131 | Suspended |
0.7063 | Intermediate Similarity | NPD3692 | Discontinued |
0.7059 | Intermediate Similarity | NPD864 | Approved |
0.7059 | Intermediate Similarity | NPD1336 | Approved |
0.7059 | Intermediate Similarity | NPD865 | Approved |
0.7054 | Intermediate Similarity | NPD3049 | Approved |
0.7049 | Intermediate Similarity | NPD4095 | Clinical (unspecified phase) |
0.7045 | Intermediate Similarity | NPD2429 | Approved |
0.7045 | Intermediate Similarity | NPD2428 | Approved |
0.7042 | Intermediate Similarity | NPD2460 | Phase 3 |
0.7042 | Intermediate Similarity | NPD2459 | Approved |
0.7042 | Intermediate Similarity | NPD2458 | Approved |
0.7042 | Intermediate Similarity | NPD5061 | Approved |
0.7042 | Intermediate Similarity | NPD5062 | Approved |
0.7021 | Intermediate Similarity | NPD6809 | Clinical (unspecified phase) |
0.7014 | Intermediate Similarity | NPD2422 | Clinical (unspecified phase) |
0.7014 | Intermediate Similarity | NPD3845 | Phase 1 |
0.7014 | Intermediate Similarity | NPD3122 | Phase 3 |
0.7007 | Intermediate Similarity | NPD3532 | Approved |
0.7007 | Intermediate Similarity | NPD3530 | Approved |
0.7007 | Intermediate Similarity | NPD3531 | Approved |
PubChem CID   | 6041 |
ChEMBL   | CHEMBL1215 |
ZINC   |
Molecular Weight:   | 167.09 |
ALogP:   | -1.2775 |
MLogP:   | 2.12 |
XLogP:   | 0.464 |
# Rotatable Bonds:   | 6 |
Polar Surface Area:   | 52.49 |
# H-Bond Aceptor:   | 2 |
# H-Bond Donor:   | 3 |
# Rings:   | 1 |
# Heavy Atoms:   | 12 |